Added to YB: 2022-12-20
Pitch date: 2022-12-20
DCTH [bullish]
Delcath Systems, Inc.
+179.51%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
Market Cap
$342.5M
Pitch Price
$3.71
Price Target
N/A
Dividend
N/A
EV/EBITDA
41.20
P/E
281.11
EV/Sales
3.20
Sector
Health Care Equipment and Supplies
Category
N/A
Show full summary:
DELCATH SYSTEMS INC DCTH
A summary for this pitch has not been created yet.
Read full article (0 min)